Adherium has introduced the SmartTurbo Model 4 monitoring device for the Turbuhaler DPI. The new device includes design improvements for older patients including easier installation and removal of the inhaler and larger buttons. According to Adherium, the SmartTurbo Model 4 also has added sensors to improve feedback on correct use of the Turbuhaler. The company … [Read more...] about Adherium introduces SmartTurbo Model 4 monitoring device for Turbuhaler
Products and Services
Adherium’s SmartTouch sensor for Symbicort gets 510(k) clearance
According to SmartInhaler maker Adherium, the FDA has granted 510(K) clearance for the company's SmartTouch sensor for use with AstraZeneca's Symbicort MDI. The SmartTouch device, which fits over the inhaler, records and transmits inhaler usage data via Bluetooth. Adherium CEO Arik Anderson commented, “The SmartTouch for Symbicort is the most advanced Smartinhaler … [Read more...] about Adherium’s SmartTouch sensor for Symbicort gets 510(k) clearance
CF PharmTech raises $65 million for inhaled drug development
Chinese inhaled drug developer and CDMO CF PharmTech has raised $65M in a Series D financing round led by Future Industry Investment Fund (managed by SDIC Fund Management), the company said. The money is to be used for development of the company's own OINDPs and for expansion of its CDMO services. SDIC Fund Management Managing Direct Hai Lu said, "Drug delivery via … [Read more...] about CF PharmTech raises $65 million for inhaled drug development
Propeller Health and GSK extend deal for use of Propeller sensor with Ellipta DPIs
Propeller Health and GSK have announced that their December 2015 agreement for development of a sensor for use with the Ellipta dry powder inhaler has been expanded, and R&D activities related to the use of the Propeller platform with GSK products for asthma and COPD will continue. The Propeller clip-on sensor for the Ellipta DPI received CE mark approval and 510(k) … [Read more...] about Propeller Health and GSK extend deal for use of Propeller sensor with Ellipta DPIs
US company selling “lollipop nebulizer”
A US company is selling a device marketed under the name Loli-O that promises delivery of nebulized medication to a child in the form of a cloud that emerges around a lollipop while the child sucks on the candy. The company makes no claims of having conducted clinical trials or of having applied for FDA approval. An "instructional video" claims to "put the treat … [Read more...] about US company selling “lollipop nebulizer”
Astech Projects certified to ISO 9001:2015 standard
Laboratory automation company Astech Projects, which manufactures the Xelair, Xelize, and Xelox ranges of automated inhaler testing systems, has announced a recent transition to the ISO 9001:2015 revised international standard for Quality Management Systems (QMS). The company said, "By meeting the criteria, Astech have displayed strong leadership and management … [Read more...] about Astech Projects certified to ISO 9001:2015 standard
Lonza acquires Micro-Macinazione
Lonza has announced the acquisition of Swiss contract micronization company Micro-Macinazione. The company recently completed its acquisition of Capsugel which had acquired US micronization specialist Powdersize in 2015. Capsugel announced an expansion of its micronization capacity at the former Powdersize facility in Quakertown, PA in 2016, and that capacity came on … [Read more...] about Lonza acquires Micro-Macinazione
Aptuit to be acquired by Evotec
CDMO Aptuit, which provides inhaled drug development and clinical supply manufacturing services, will be acquired by German CRO Evotec for $300 million, the two companies have announced. Aptuit has about 750 employees at 3 sites in Italy, Switzerland, and the UK. In 2016, Aptuit acquired pre-clinical development specialist Kuecept, which also has extensive … [Read more...] about Aptuit to be acquired by Evotec
Acquisition of Capsugel by Lonza completed
Lonza's acquisition of CDMO Capsugelfrom KKR for $5.5 billion, which was initially announced in December 2016, is now complete, the company said. In 2011, Pfizer sold Capsugel to KKR for just under $2.4 billion, and in 2013, Capsugel expanded its OINDP development and manufacturing services when it acquired Bend Research. The announcement stated that, "With … [Read more...] about Acquisition of Capsugel by Lonza completed
Opiant licenses Intravail technology from Aegis Therapeutics
Intranasal drug developer Opiant Pharmaceuticals has signed an exclusive global licensing deal with Aegis Therapeutics for use of Aegis’ Intravail absorption enhancers with Opiant's opioid antagonists, the company said. No financial terms were disclosed. Opiant (formerly Lightlake Therapeutics) licensed its intranasal naloxone formulation for the reversal of opioid … [Read more...] about Opiant licenses Intravail technology from Aegis Therapeutics